A DNA
vaccine is the latest technique that immunizes individuals against
bacterial and viral diseases. In addition to this, it also offers protection
against parasitic and fungal infections. The vaccine injects engineered DNA
into the host body for cells to directly produce an antigen and trigger an immunologic
response against cancer, parasites, bacteria, and viruses. Though still in
development, the latest vaccination technology promises advantages such as
enhanced immunity, specific targeting, and reduced risk compared to
conventional vaccines. The third-generation vaccine technology is continuously
improving as researchers study its application in combating HIV and certain
kinds of cancer. Besides, the rise in rapid development in molecular biology
and immunology is also a crucial factor driving growth across the DNA vaccines
market.
For
More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/dna-vaccines-market
Growing Incidence of Cancer and Infectious
Diseases to Aid DNA Vaccines Market Expansion
The rising global population and growing
cancer risk factors are accelerating the incidence of cancer. Inflated
prevalence of cancer and other infectious diseases is concurrently elevating
the demand for DNA vaccines. Numerous benefits of DNA vaccines include room
temperature stability, greater efficacy, and accessible transportation.
Moreover, DNA vaccines also stimulates the response of the immune system to
cancer. With next-generation advancements, the DNA vaccines are set to
demonstrate greater strength against such chronic diseases. An incessant rise
in the number of cancer cases is expected to increase the adoption of DNA
vaccines in the years to follow. This in turn will fuel the DNA vaccines market
growth.
Rising Pet Population to Create New Avenues
for DNA Vaccines Market
The growing pet population has led to increase
in demand for pet immunizations. Pets require immunizations, initial
inspections, and neutering in the beginning. Then, the veteran intervention
increases in their later years. Growing incidence of animal disease, animal
hospital admission for vaccine doses, and the availability of trained
veterinarians in hospitals is boosting demand for DNA vaccines. Furthermore,
over the last decade, the global cattle population has also increased at a
significant pace, creating tailwinds for market growth. Other factors such as
nutritional and lifestyle changes are also contributing to the veterinary
hospital sector's growth. Such a favourable scenario is likely to unlock the
new phase of growth for the DNA vaccines market.
North America to Emerge as a Key Regional
Market Amid Surge in Prevalence of Diseases
North America is the only country to approve
certain specific treatments, hence, the region' cements dominance in the DNA
vaccines market. Furthermore, the rapid development in immunology and molecular
biology, rise in prevalence of HIV and other diseases, and supporting government
efforts are facilitating regional market expansion. The presence of key market
players in the region and well-established veterinary organisational structures
also play an essential role in the market growth. Against this backdrop, the
DNA vaccines market in North America is likely to experience exponential
growth.
Prominent Market Players
Some of the major players in the DNA vaccines
market include Genexine, VIATRIS INC. (Rottapharm Biotech), Takara Holdings
(Takara Bio), GEOVAX LABS, INC, ELI-LILLY (Novartis Animal Health), Inovio
Pharmaceuticals (VGX Animal Health), GeneOne Life Science, BOEHRINGER INGELHEIM
GmbH (Merial), ZOETIS INC. (Fort Dodge Animal Health), and Zydus Cadila.
For More Information Visit: https://www.fairfieldmarketresearch.com/report/dna-vaccines-market
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield
offers a wide spectrum of services, ranging from customized reports to
consulting solutions. With a strong European footprint, Fairfield operates
globally and helps businesses navigate through business cycles, with quick
responses and multi-pronged approaches. The company values an eye for
insightful take on global matters, ably backed by a team of exceptionally
experienced researchers. With a strong repository of syndicated market research
reports that are continuously published & updated to ensure the
ever-changing needs of customers are met with absolute promptness.
